Clonidine (Catapres, Kapvay) is a central alpha-2 adrenergic agonist used for hypertension, ADHD in children 6–17, opioid withdrawal management, and Tourette syndrome. It works by stimulating alpha-2 receptors in the brainstem, reducing sympathetic nervous system output to lower blood pressure and heart rate. Common side effects include sedation, dry mouth, and orthostatic hypotension. A critical warning: abrupt discontinuation can trigger dangerous rebound hypertension — always taper gradually under medical supervision.
Clonidine
Uses & FDA Indications
Clonidine was originally developed as an antihypertensive and remains a useful option for blood pressure management, particularly in situations where rapid action is needed. Over decades of clinical use, its sympatholytic properties have proven valuable across a surprising range of conditions.
FDA-approved indications include: hypertension (Catapres tablets and patch), and ADHD in children aged 6–17 (Kapvay extended-release, as monotherapy or adjunct to stimulants). The extended-release formulation Nexiclon XR is also approved for hypertension.
Widely recognized off-label uses include: opioid and alcohol withdrawal (managing autonomic symptoms — sweating, tachycardia, hypertension, agitation), Tourette syndrome and tic disorders, hot flashes in menopausal women and in men undergoing androgen deprivation therapy, performance and situational anxiety, and restless leg syndrome. Its use in opioid withdrawal is particularly well-established in clinical practice, where it blunts the severe sympathetic storm that accompanies abrupt opioid cessation.
How It Works
Clonidine is a centrally acting alpha-2 adrenergic receptor agonist. Its primary site of action is the locus coeruleus and other brainstem nuclei that regulate sympathetic outflow to the peripheral nervous system. By stimulating presynaptic alpha-2 receptors in the brainstem, clonidine acts as a "brake" on the sympathetic nervous system — reducing the release of norepinephrine from sympathetic nerve terminals throughout the body.
The downstream effects of this reduced sympathetic tone include: decreased heart rate (negative chronotropy), decreased cardiac output, peripheral vasodilation, and a net reduction in blood pressure. These effects are most pronounced in the upright position, which is why orthostatic hypotension is a common side effect.
In ADHD, the mechanism is somewhat different. Alpha-2A receptors in the prefrontal cortex act postsynaptically to strengthen signal transmission in circuits involved in attention, impulse control, and working memory. Stimulating these receptors improves the "signal-to-noise ratio" in prefrontal networks — an effect complementary to, but mechanistically distinct from, stimulant medications that work primarily through dopamine and norepinephrine release.
The transdermal clonidine patch (Catapres-TTS) delivers medication continuously over 7 days and maintains steadier blood levels than oral tablets, reducing peak-related sedation. However, used patches still contain significant amounts of active drug and must be carefully folded and disposed of — accidental contact or ingestion (especially by children) has caused serious toxicity.
REBOUND HYPERTENSION — NEVER STOP ABRUPTLY: Abrupt discontinuation of clonidine causes a rebound withdrawal syndrome within 12–24 hours: severe hypertension (sometimes exceeding pretreatment levels), tachycardia, agitation, headache, tremor, and sweating. This rebound can precipitate hypertensive crisis, stroke, or myocardial infarction in high-risk patients. Always taper clonidine gradually over days to weeks. If clonidine must be discontinued urgently, substitute an alternative antihypertensive and monitor blood pressure closely.
Side Effects
Common
- Sedation / drowsiness — one of the most common and clinically significant side effects; often most pronounced in the first few weeks and can persist; limits use in patients requiring alertness
- Dry mouth — very common; caused by reduced salivary gland sympathetic stimulation
- Constipation — reduced gastrointestinal motility from decreased sympathetic tone
- Hypotension and orthostatic hypotension — particularly on standing; risk of falls, especially in elderly patients
- Bradycardia — reduced heart rate; usually mild but clinically significant when combined with other rate-lowering drugs
- Dizziness, fatigue, headache
- Skin reactions — with the patch formulation; contact dermatitis occurs in up to 20% of users; rotate application sites
Serious
- Rebound hypertension — on abrupt withdrawal; potentially life-threatening (see Warnings)
- Severe bradycardia and heart block — especially when combined with beta blockers or other rate-lowering agents
- Pediatric overdose toxicity — clonidine is disproportionately toxic to children; even one tablet can cause profound sedation, bradycardia, hypotension, respiratory depression, and coma in a toddler; consider clonidine tablets a pediatric poisoning hazard and store accordingly
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Beta Blockers (metoprolol, atenolol, propranolol) | Two distinct risks: (1) additive bradycardia during concurrent use; (2) on clonidine withdrawal, beta blockers can worsen rebound hypertension by blocking the vasodilatory beta-2 receptors, leaving alpha-mediated vasoconstriction unopposed. If discontinuing both, taper clonidine first, then the beta blocker. | High — requires careful sequencing during discontinuation; monitor heart rate during concurrent use |
| CNS Depressants (alcohol, benzodiazepines, opioids, sedating antihistamines) | Additive CNS and respiratory depression; clonidine's intrinsic sedation is amplified by other depressants. Combination with opioids raises particular concern for respiratory depression. | Moderate-High — minimize combination; counsel patients on additive sedation |
| Antihypertensives (any class) | Additive blood pressure lowering effect; can cause excessive hypotension, dizziness, and falls — especially in elderly patients or those starting new antihypertensive therapy. | Moderate — monitor blood pressure when adding or changing antihypertensives |
| Tricyclic Antidepressants (amitriptyline, nortriptyline, imipramine) | TCAs antagonize alpha-2 receptors, directly opposing clonidine's mechanism and significantly reducing its antihypertensive efficacy. Blood pressure control can be lost even at standard TCA doses. | High — consider alternative antidepressant; if TCA necessary, monitor blood pressure closely and consider alternative antihypertensive |
| Moxonidine / other centrally acting antihypertensives | Additive central sympatholytic effects; excessive blood pressure reduction and sedation. | Moderate — generally avoid combination |
Warnings & Contraindications
Contraindications
- Hypersensitivity to clonidine
- Known sick sinus syndrome or AV block in patients without a pacemaker (relative — bradycardia risk)
Patch Disposal Warning
Used clonidine patches retain a substantial amount of active drug — often 30–50% of the original content. Patches must be folded sticky side together and disposed of safely out of reach of children and pets. Accidental skin contact with a used patch can deliver a significant dose of clonidine. Several pediatric fatalities have occurred from ingestion of discarded patches.
Use in Children
Clonidine is among the most toxic medications for young children on a per-weight basis. Ingestion of even a single adult tablet can be life-threatening to a toddler. If clonidine is prescribed in a household with young children, counsel on strict storage and disposal practices. Emergency Poison Control: 1-800-222-1222.
Check for interactions between clonidine and your other medications.
Check Drug Interactions →Frequently Asked Questions
Does clonidine help with anxiety?
Clonidine is used off-label for anxiety, particularly for the physical symptoms associated with anxiety and stress responses — rapid heart rate, sweating, tremor, and elevated blood pressure that accompany panic or situational anxiety. By reducing sympathetic nervous system output from the brainstem, it blunts the physiological "fight or flight" response. It is not a first-line anxiolytic and does not address the cognitive or emotional components of anxiety the way SSRIs or therapy do. It is sometimes used in settings like opioid withdrawal to manage the severe autonomic symptoms that accompany withdrawal anxiety.
Is clonidine a controlled substance?
No — clonidine is not classified as a controlled substance by the DEA. It does not carry meaningful abuse or dependence potential in the traditional sense. However, physical dependence does develop with regular use, meaning abrupt discontinuation can trigger rebound hypertension that can be severe and even dangerous. This is a physiological dependence related to the body's adaptation to reduced sympathetic tone — not the behavioral dependence or euphoria-seeking behavior associated with controlled substances. Always taper clonidine gradually under medical supervision rather than stopping suddenly.
What does clonidine do for ADHD?
Clonidine (as extended-release Kapvay) is FDA-approved for ADHD in children aged 6–17, both as a standalone treatment and as an adjunct to stimulant medications. Its mechanism in ADHD is distinct from stimulants: rather than increasing dopamine and norepinephrine release, it directly stimulates alpha-2A adrenergic receptors in the prefrontal cortex. This postsynaptic receptor stimulation strengthens the "signal" in prefrontal networks involved in attention regulation, impulse control, and working memory. Clonidine is particularly useful for managing the hyperactive and impulsive symptoms of ADHD and is often paired with stimulants to also address inattention. It does not carry the abuse potential of stimulant ADHD medications.